Aster DM Healthcare promoters cut pledged shares to 41% after debt refinancing

The promoters of healthcare player, Aster DM Healthcare had reduced their share pledge from 99 per cent to 41 per cent after completing a debt refinancing transaction from top-tier global financial institutions.

As part of the refinancing process, the new reputed lenders—JP Morgan, HSBC, and Barclays—provided fresh funding, enabling Aster DM Healthcare promoters to refinance its existing loans at better terms and loan-to-value (LTV).

Dr. Azad Moopen, Founder and Chairman of Aster DM Healthcare, said, “The reduction in Aster’s pledged shares reflects our financial strength as promoters, amid the volatile global market conditions. This development also strengthens trust among stakeholders, investors, and partners as we expand in India.”

Aster operates in India with a strong presence across primary, secondary, tertiary, and quaternary healthcare through 19 hospitals with 5,128 beds, 13 clinics, 203 pharmacies (Operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster), and 254 labs and patient experience centers across 5 states in India.

The company reported an increase in adjusted net profit (post NCI) by 30 per cent year-on-year (YoY) to ₹81 crore for its India business in Q3 FY25, up from ₹62 crore in Q3FY24. The revenue stood at ₹1,050 crore, and operating EBITDA was up by 20 per cent YoY to ₹202 crore.

• Also read: Stock Market Live Updates 12 March 2025: Sensex, Nifty extend losses; IndusInd rebounds over 3%, tech stocks slide